Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin. Latest News BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018 The FDA approved the first oral treatment for breast cancer patients who have inherited mutations in their BRCA genes. Susan Domchek, MD, who was involved in the clinical trial, discusses how this is a major step forward. Faith, Fate, and Families Penn Medicine Magazine News | February 2018 Penn Medicine Magazine's latest issue includes the story of how the Basser Center was founded in memory of Faith Basser, and how BRCA mutations can impact families around the world. Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 The U.S. Food and Drug Administration recently approved olaparib as the first treatment for advanced breast cancer caused by mutations in BRCA genes, in an important step in the fight against inherited cancers. Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Susan Domchek, MD, Executive Director of the Basser Center, discussed the evolving treatment landscape for patients with BRCA-related, metastatic breast cancer. Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Last week, journalist Joan Lunden moderated a panel of experts, “Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk.” The program, co-presented by the Basser Center, focused on the latest lifesaving information surrounding BRCA-related cancers. Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Basser Center co-founder Mindy Gray's family is in the news, thanks to her inspiring father, Phil Basser, whose love of the Eagles has gone viral just before his 100th birthday. Olaparib/Durvalumab Combo Effective for BRCA-mutant Breast Cancer OncLive News | December 2017 OncLive reports on recent Penn-led research showing that the combination of olaparib and durvalumab demonstrated a disease control rate of 80 percent for pretreated patients with germline BRCA-mutated, HER2- negative metastatic breast cancer. Can Telomere Length Reveal How Well You’re Aging? Good Morning America News | November 2017 TeloYears is an at-home test that promises to reveal a user's true biological age by measuring telomeres, the ends of chromosomes that wear down over time. Susan Domchek, MD, advised caution, saying there has to be more study. For Cancer Survivor, the Bell Tolls Loudly Bloomberg News | November 2017 The biennial Basser Jean Bash celebrated five years of progress toward understanding, treating and preventing hereditary cancers. The benefit honored Raquel and Michael Hass and Pulitzer Prize-winning author Siddhartha Mukherjee, MD, DPhil. Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017 Basser's Angela Bradbury, MD, says one of the biggest challenges is that many patients don't have access to genetic counselors. A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It Forbes News | September 2017 Forbes takes a deep dive into the use of PARP inhibitors in the fight against pancreatic cancer, which features a recently opened trial led by Kim A. Reiss Binder, MD, an assistant professor of Hematology Oncology. Why the Breast Cancer Gene You May Never Have Heard of Could Matter Philadelphia Inquirer News | September 2017 A local woman and her family discuss how they have been affected by cancers caused by a PALB2 gene mutation, a gene that works to repair broken strands of DNA. Like BRCA, it potentially increases an individual's risk of certain cancers. Ethical Dilemmas Arise from Genetic Testing for Cancer Cure Magazine News | June 2017 CURE Magazine discusses the complicated issue of genetic testing, with input from the experts on the Basser Center's April 25th panel in Manhattan, which included Executive Director, Dr. Susan Domchek. Hope and Hype Around Cancer Immunotherapy CNN News | June 2017 Immunotherapy treatments are on the rise. The Abramson Cancer Center's Dr. Robert Vonderheide, in collaboration with the Basser Center, is leading vaccine-based trials for the prevention of cancers associated with BRCA gene mutations. Penn Effort to Expand Trials of Olaparib Leads to New Treatment Options for Patients with Advanced BRCA-Related Breast Cancer Penn Medicine News News | June 2017 At the American Society of Clinical Oncology Annual Meeting, an international team of scientists presented the results of the phase III OlympiAD trial demonstrating for the first time that olaparib is superior to chemotherapy in patients with BRCA-related advanced breast cancer. Blackstone's Gray Gives $21 Million to Hit Cancer Close to Home Bloomberg News | May 2017 A new $21 million gift to the Basser Center from Penn alumni Mindy and Jon Gray will cement and propel Penn’s preeminence as a leader in research to improve treatment and prevention strategies for hereditary cancers. Ask the Experts: How to Talk About Family Medical History at Thanksgiving Philadelphia Inquirer News | November 2016 Getting together with relatives can be the perfect opportunity to discuss your family medical history. Basser Center genetic counselors Danielle McKenna, Amanda Brandt, and Dana Clark discuss how best to approach the topic. In the War Against Cancer, Modesty is Not an Ally Toronto Star News | November 2016 An article from the Toronto Star profiles Steven Narod, MD, FRCPC, FRSC, director of the Familial Breast Cancer Research Unit and a senior scientist at the Women’s College Hospital in Toronto, whose seminal work on BRAC earned him this year's Basser Global Prize. Pagination First page« First Previous page‹‹ … Page7 Page8 Page9 Page10 Page11 Page12 Page13 Current page14 Page15 Next page›› Last pageLast »
Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin.
BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018 The FDA approved the first oral treatment for breast cancer patients who have inherited mutations in their BRCA genes. Susan Domchek, MD, who was involved in the clinical trial, discusses how this is a major step forward.
Faith, Fate, and Families Penn Medicine Magazine News | February 2018 Penn Medicine Magazine's latest issue includes the story of how the Basser Center was founded in memory of Faith Basser, and how BRCA mutations can impact families around the world.
Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 The U.S. Food and Drug Administration recently approved olaparib as the first treatment for advanced breast cancer caused by mutations in BRCA genes, in an important step in the fight against inherited cancers.
Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Susan Domchek, MD, Executive Director of the Basser Center, discussed the evolving treatment landscape for patients with BRCA-related, metastatic breast cancer.
Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Last week, journalist Joan Lunden moderated a panel of experts, “Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk.” The program, co-presented by the Basser Center, focused on the latest lifesaving information surrounding BRCA-related cancers.
Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Basser Center co-founder Mindy Gray's family is in the news, thanks to her inspiring father, Phil Basser, whose love of the Eagles has gone viral just before his 100th birthday.
Olaparib/Durvalumab Combo Effective for BRCA-mutant Breast Cancer OncLive News | December 2017 OncLive reports on recent Penn-led research showing that the combination of olaparib and durvalumab demonstrated a disease control rate of 80 percent for pretreated patients with germline BRCA-mutated, HER2- negative metastatic breast cancer.
Can Telomere Length Reveal How Well You’re Aging? Good Morning America News | November 2017 TeloYears is an at-home test that promises to reveal a user's true biological age by measuring telomeres, the ends of chromosomes that wear down over time. Susan Domchek, MD, advised caution, saying there has to be more study.
For Cancer Survivor, the Bell Tolls Loudly Bloomberg News | November 2017 The biennial Basser Jean Bash celebrated five years of progress toward understanding, treating and preventing hereditary cancers. The benefit honored Raquel and Michael Hass and Pulitzer Prize-winning author Siddhartha Mukherjee, MD, DPhil.
Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017 Basser's Angela Bradbury, MD, says one of the biggest challenges is that many patients don't have access to genetic counselors.
A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It Forbes News | September 2017 Forbes takes a deep dive into the use of PARP inhibitors in the fight against pancreatic cancer, which features a recently opened trial led by Kim A. Reiss Binder, MD, an assistant professor of Hematology Oncology.
Why the Breast Cancer Gene You May Never Have Heard of Could Matter Philadelphia Inquirer News | September 2017 A local woman and her family discuss how they have been affected by cancers caused by a PALB2 gene mutation, a gene that works to repair broken strands of DNA. Like BRCA, it potentially increases an individual's risk of certain cancers.
Ethical Dilemmas Arise from Genetic Testing for Cancer Cure Magazine News | June 2017 CURE Magazine discusses the complicated issue of genetic testing, with input from the experts on the Basser Center's April 25th panel in Manhattan, which included Executive Director, Dr. Susan Domchek.
Hope and Hype Around Cancer Immunotherapy CNN News | June 2017 Immunotherapy treatments are on the rise. The Abramson Cancer Center's Dr. Robert Vonderheide, in collaboration with the Basser Center, is leading vaccine-based trials for the prevention of cancers associated with BRCA gene mutations.
Penn Effort to Expand Trials of Olaparib Leads to New Treatment Options for Patients with Advanced BRCA-Related Breast Cancer Penn Medicine News News | June 2017 At the American Society of Clinical Oncology Annual Meeting, an international team of scientists presented the results of the phase III OlympiAD trial demonstrating for the first time that olaparib is superior to chemotherapy in patients with BRCA-related advanced breast cancer.
Blackstone's Gray Gives $21 Million to Hit Cancer Close to Home Bloomberg News | May 2017 A new $21 million gift to the Basser Center from Penn alumni Mindy and Jon Gray will cement and propel Penn’s preeminence as a leader in research to improve treatment and prevention strategies for hereditary cancers.
Ask the Experts: How to Talk About Family Medical History at Thanksgiving Philadelphia Inquirer News | November 2016 Getting together with relatives can be the perfect opportunity to discuss your family medical history. Basser Center genetic counselors Danielle McKenna, Amanda Brandt, and Dana Clark discuss how best to approach the topic.
In the War Against Cancer, Modesty is Not an Ally Toronto Star News | November 2016 An article from the Toronto Star profiles Steven Narod, MD, FRCPC, FRSC, director of the Familial Breast Cancer Research Unit and a senior scientist at the Women’s College Hospital in Toronto, whose seminal work on BRAC earned him this year's Basser Global Prize.
